← Back to Search

Storytelling to Promote Living Donor Kidney Transplant (LDKT Stories Trial)

N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Waitlisted and newly referred kidney transplant candidates at the Vancouver Kidney Transplant Program
* 18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This study will examine the effectiveness of first-person storytelling in encouraging patients with end-stage renal disease to pursue Living Donor Kidney Transplant (LDKT). The Living Donation Storytelling Library LDSP is a library of videos from donors and recipients sharing their transplant stories, serving as a narrative-based transplant education resource. This study will investigate if exposure to the LDSP changes patient readiness and motivation to pursue LDKT to ultimately increase the number of donor inquiries and donor evaluations. This study will also test if the LDSP serves as a health-literate and culturally safe education approach that can effectively support racialized communities who have a disproportionately higher need for LDKT.

Eligible Conditions
  • Kidney Transplant
  • Health Equity
  • Patient Education
  • Narrative Medicine

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Readiness and Motivation
Transplant Actions
Secondary study objectives
Donor Inquiries and evaluations
Other study objectives
Health literacy and cultural safety
Transplant knowledge

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment2 Interventions
2 storytelling videos in addition to standard of care patient education materials
Group II: ControlActive Control1 Intervention
Standard of care patient education materials
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard Patient Education
2021
N/A
~120

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,479 Previous Clinical Trials
2,494,467 Total Patients Enrolled
Houston Methodist Transplant & Surgery Center of ExcellenceUNKNOWN
~53 spots leftby Aug 2025